Ferguson Wellman Capital Management, Inc
Source: SEC Form 13F · as of Mar 2026Ferguson Wellman Capital Management, Inc holds 18 biotech & pharma companies tracked by BioSniper, totaling $665.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$665.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 650,411 | $141.5M |
| JNJJOHNSON & JOHNSON | 469,028 | $114.6M |
| AMGNAMGEN INC | 319,238 | $112.3M |
| PMPhilip Morris International Inc | 482,648 | $79.8M |
| CORCencora Inc. | 212,070 | $66.6M |
| MRKMerck & Co., Inc. | 385,956 | $46.4M |
| NVSNovartis AG | 182,356 | $27.9M |
| MCKMcKesson Corporation | 27,301 | $23.6M |
| LLYELI LILLY & Co | 21,116 | $19.4M |
| ABTABBOTT LABORATORIES | 176,556 | $18.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 24,551 | $6.6M |
| BMYBRISTOL MYERS SQUIBB CO | 46,278 | $2.8M |
| GILDGILEAD SCIENCES, INC. | 15,327 | $2.1M |
| CAHCardinal Health Inc. | 5,280 | $1.1M |
| PFEPFIZER INC | 31,358 | $881K |
| ZTSZoetis Inc. | 7,091 | $838K |
| ZBHZimmer Biomet Holdings Inc. | 2,626 | $237K |
| GEHCGE HealthCare Technologies Inc. | 2,993 | $213K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.